However, NRP1 overexpression in tumor cells is associated not only with angiogenesis but also with PCa cells developing resistance to androgen-targeted therapy and progression to metastatic castration-resistant prostate cancer (mCRPC). This evidence concerns the gene NRP1 and neoplasm.